Nrx Pharmaceuticals, INC. (NRXPW) SEC Filings — 2025

Filings

• NRX Pharmaceuticals Files 8-K — 8-K · Dec 29, 2025
• Nrx Pharmaceuticals, INC. 8-K Filing — 8-K · Nov 26, 2025
• Nrx Pharmaceuticals, INC. 8-K/A Filing — 8-K/A · Nov 21, 2025
• NRX Pharmaceuticals' Net Loss Widens Amidst R&D Shifts, Revenue Debut — 10-Q · Nov 14, 2025
• NRX Pharmaceuticals Files 8-K — 8-K · Oct 23, 2025
• NRX Pharmaceuticals Files 8-K — 8-K · Sep 26, 2025
• NRX Pharmaceuticals Completes Asset Acquisition/Disposition — 8-K · Sep 12, 2025
• NRX Pharmaceuticals Files 8-K with Financials — 8-K · Sep 8, 2025
• NRX Pharmaceuticals Q2 2025 Update: Revenue Flat, Assets Shift — 10-Q · Aug 18, 2025
• NRX Pharmaceuticals Files 8-K — 8-K · Aug 15, 2025
• NRX Pharmaceuticals Files 8-K Report — 8-K · Jun 9, 2025
• NRX Pharmaceuticals Files 8-K on Financials — 8-K · May 21, 2025
• NRX Pharmaceuticals Q1 2025: Minimal Revenue, Significant Cash — 10-Q · May 15, 2025
• NRX Pharmaceuticals Files 8-K — 8-K · May 13, 2025
• NRX Pharmaceuticals Files 2024 Annual Report Amendment — 10-K/A · Apr 30, 2025
• NRX Pharmaceuticals Files 8-K — 8-K · Apr 17, 2025
• NRX Pharmaceuticals Files 8-K on Financials — 8-K · Mar 21, 2025
• NRX Pharmaceuticals Files 2024 10-K — 10-K · Mar 14, 2025
• NRX Pharmaceuticals Files 8-K — 8-K · Feb 3, 2025
• NRX Pharmaceuticals Files 8-K: Agreements & Equity Sales — 8-K · Jan 29, 2025
• NRX Pharmaceuticals Files 8-K on Officer/Director Changes — 8-K · Jan 22, 2025
• NRX Pharmaceuticals Appoints New CMO, Elects Directors — 8-K · Jan 14, 2025
• NRX Pharmaceuticals Files 8-K for Equity Sales — 8-K · Jan 10, 2025